MedTrace Logo

French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS)

NCT01831128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 509

Last updated 2021-02-02

No results posted yet for this study

Summary

The purpose of FACE study is to provide in routine practice complementary long-term data on the mortality and morbidity of Chronic Heart Failure (CHF) patients with Central Sleep Apnea eligible for Adaptative Servo-Ventilation (ASV) treatment (PaceWave, AutoSet CS; ResMed).

Conditions

Interventions

DEVICE

ASV Treatment

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Principal Investigators

  • Marie-Pia d'ORTHO, MD, PhD · APHP (Assistance Publique Hôpitaux de Paris) - Bichat-Claude Bernard Hospital, Paris

  • Jean-Louis PEPIN, MD, PhD · Grenoble University Hospital, Grenoble

  • Jean-Marc DAVY, MD, PhD · Arnaud de Villeneuve University Hospital, Montpellier

  • Thibaud DAMY, MD, PhD · APHP - Henri Mondor University Hospital, Creteil

  • Patrick LEVY, MD, PhD · Grenoble University Hospital, Grenoble

  • Renaud TAMISIER, MD, PhD · Grenoble University Hospital, Grenoble

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-11-30
Primary Completion
2020-09-30
Completion
2020-09-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01831128 on ClinicalTrials.gov